Nazir Ismail

Effects of conditional cash transfers and pre-test and post-test tuberculosis counselling on patient outcomes and loss to follow-up across the continuum of care in South Africa: a randomised controlled trial

Clinical standards for antimicrobial stewardship in TB care

Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development

Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene approach

The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis—lessons from the South African experience

Systematic review of the economic impact of novel Mycobacterium tuberculosis specific antigen-based skin tests for detection of TB infection compared with tuberculin skin test and interferon-gamma release assays

Careful classification of potential bedaquiline resistance mutations is critical when analysing their clinical impact

Assessing the Diagnostic Performance of New Commercial Interferon-γ Release Assays for<i>Mycobacterium tuberculosis</i>Infection: A Systematic Review and Meta-Analysis

Updating the WHO target product profile for next-generation Mycobacterium tuberculosis drug susceptibility testing at peripheral centres

Genotype–Phenotype Characterization of Serial <i>Mycobacterium tuberculosis</i> Isolates in Bedaquiline-Resistant Tuberculosis

Economic evaluation of novel Mycobacterium tuberculosis specific antigen-based skin tests for detection of TB infection: A modelling study

High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region

Prior Pulmonary Tuberculosis Is a Risk Factor for Asymptomatic Cryptococcal Antigenemia in a Cohort of Adults With Advanced Human Immunodeficiency Virus Disease

Effectiveness and Cardiac Safety of Bedaquiline-Based Therapy for Drug-Resistant Tuberculosis: A Prospective Cohort Study

Tryptophan catabolism reflects disease activity in human tuberculosis

MDR M. tuberculosis outbreak clone in Eswatini missed by Xpert has elevated bedaquiline resistance dated to the pre-treatment era

Validation of Bedaquiline Phenotypic Drug Susceptibility Testing Methods and Breakpoints: a Multilaboratory, Multicountry Study

A Multimethod, Multicountry Evaluation of Breakpoints for Bedaquiline Resistance Determination

Antibiotic resistance prediction for Mycobacterium tuberculosis from genome sequence data with Mykrobe

Cryptococcal-related Mortality Despite Fluconazole Preemptive Treatment in a Cryptococcal Antigen Screen-and-Treat Program

Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South Africa

Pre-detection history of extensively drug-resistant tuberculosis in KwaZulu-Natal, South Africa

Extensively drug-resistant tuberculosis ‘hotspots' and sociodemographic associations in Durban, South Africa

Data quality of drug-resistant tuberculosis and antiretroviral therapy electronic registers in South Africa

Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study

Using mHealth to improve tuberculosis case identification and treatment initiation in South Africa: Results from a pilot study

Spatial Patterns of Extensively Drug-Resistant Tuberculosis Transmission in KwaZulu-Natal, South Africa

Extensively drug-resistant tuberculosis in South Africa: genomic evidence supporting transmission in communities

Transmission of Extensively Drug-Resistant Tuberculosis in South Africa

Some Synonymous and Nonsynonymous <i>gyrA</i> Mutations in Mycobacterium tuberculosis Lead to Systematic False-Positive Fluoroquinolone Resistance Results with the Hain GenoType MTBDR <i>sl</i> Assays